EBIT: Income before interest and taxes.
Cabaletta Bio, Inc. (CABA) had EBIT of $-45.91M for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
-- |
|
$-45.13M |
|
-- |
|
-- |
|
$45.91M |
|
$-45.91M |
|
$0.78M |
|
$-45.13M |
|
$-45.13M |
|
$-45.13M |
|
$-45.13M |
|
$-45.13M |
|
$-45.13M |
|
EBIT |
$-45.91M |
$-45.33M |
|
61.88M |
|
61.88M |
|
$-0.73 |
|
$-0.73 |
|
Balance Sheet Financials | |
$198.41M |
|
$2.37M |
|
$26.09M |
|
$224.50M |
|
$41.54M |
|
-- |
|
$4.48M |
|
$46.02M |
|
$178.48M |
|
$178.48M |
|
$178.48M |
|
91.45M |
|
Cash Flow Statement Financials | |
$-61.23M |
|
$-49.98M |
|
$92.82M |
|
$163.96M |
|
$145.61M |
|
$-18.35M |
|
$10.87M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
4.78 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-62.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.28% |
|
-25.28% |
|
-20.10% |
|
-25.28% |
|
$1.95 |
|
$-1.00 |
|
$-0.99 |